|
06 Dec 2010 |
Generex Presents New Positive AE37 Phase II Breast Cancer Vaccine Data
|
|
06 Dec 2010 |
Fraunhofer USA CMB Initiates Phase I Clinical Trial for Avian (H5N1) Influenza Vaccine
|
|
06 Dec 2010 |
GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
|
|
03 Dec 2010 |
Microbix Biosystems Forms Influenza Vaccine Subsidiary, Crucible International Biotechnologies
|
|
02 Dec 2010 |
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
|
|
30 Nov 2010 |
Mymetics HIV Vaccine Shows Strong Preliminary Phase I Data
|
|
30 Nov 2010 |
NanoBio Receives $6 Million to Develop an Intranasal Vaccine for Respiratory Syncytial Virus (RSV)
|
|
30 Nov 2010 |
Argos Therapeutics Initiates Dosing of Patients in Phase 2b Clinical Trial of Arcelis Personalized Immunotherapy for Treatment of HIV Patients
|
|
29 Nov 2010 |
Sanofi Pasteur Starts a Phase II Vaccine Trial for Primary Prevention of Clostridium Difficile
|
|
25 Nov 2010 |
VIVALIS : ACHIEVES A SIGNIFICANT MILESTONE WITH THE ACCEPTANCE OF AN INVESTIGATIONAL NEW DRUG FILING (IND) FOR A CANDIDATE INFLUENZA VACCINE USING EB66 CELL-BASED TECHNOLOGY
|
|
24 Nov 2010 |
Advaxis India Cervix Cancer Trial Begins Dosing
|
|
22 Nov 2010 |
Celldex Therapeutics Reports Positive Results from Rindopepimut Phase 2 Brain Cancer Study at SNO 2010
|
|
18 Nov 2010 |
Further Analysis of Vacc-4x Phase IIb Study Shows a Statistically Significant Reduction in Viral Load Over Placebo -- Previous Decision to Put Vacc-4x on Hold Has Been Reversed
|
|
18 Nov 2010 |
FDA Advisory Committee Supports Approval of Merck & Co.'s GARDASIL(R) for Prevention of Anal Cancer and AIN in both Men and Women
|
|
17 Nov 2010 |
Inovio Pharmaceuticals’ HIV DNA Vaccine Achieves Strong T-Cell Immune Responses in Phase I Human Trial
|
|
17 Nov 2010 |
Immunovaccine Inc. Announces Phase I/II Clinical Plan for DPX-Survivac to Target Ovarian Cancer
|
|
12 Nov 2010 |
London Genetics and Astrimmune to Collaborate on Cancer Vaccine
|
|
11 Nov 2010 |
Pevion's Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study
|
|
10 Nov 2010 |
Diamyd Completes Screening for US Phase III Study
|
|
09 Nov 2010 |
Nabi Biopharmaceuticals Completes Enrollment of Second NicVAX Phase III Clinical Trial
|
|
08 Nov 2010 |
Advaxis Enters into Collaboration with the University of British Columbia
|
|
05 Nov 2010 |
New clinical study started with the nicotine vaccine NIC002
|
|
04 Nov 2010 |
Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development
|
|
04 Nov 2010 |
Novel Recombinant Chikungunya Virus Vaccine Shown to be Safe and Effective in Multiple Animal Models
|
|
02 Nov 2010 |
Soligenix Announces Completion of Enrollment and Preliminary Safety Results of a Phase 1B Clinical Trial for RiVax
|
